Park Dental Partners, Inc.

8-K · tm2616585d1_8k.htm iXBRL

0002069604

 2026-05-29
 2026-05-29

 iso4217:USD

 xbrli:shares

 iso4217:USD

 xbrli:shares

  

  

  

 UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

  

 FORM 8-K

  

 CURRENT REPORT

 Pursuant to Section 13 or 15(d)

 of the Securities Exchange Act of 1934

  

 Date of Report (Date of earliest event reported):
 May 29, 2026

  

 Park Dental Partners,
Inc.

 (Exact Name of Registrant as Specified in its
Charter)

  

 Minnesota  
 001-42967  
 93-2020683

 (State or Other Jurisdiction of  
 (Commission  
 (IRS Employer

 Incorporation)  
 File Number)  
 Identification No.)

  

 2200 County Road C West , Suite 2210

 Roseville , Minnesota 55113

 (Address of Principal Executive Offices) (Zip
Code)  

  

 ( 651 )
 633-0500

 (Registrant's Telephone Number, Including Area Code)

  

 Not Applicable

 (Former Name or Former Address, if Changed Since Last Report)

  

 Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  

 ¨ Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)

 ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)

 ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))

 ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))

  

 Securities registered pursuant to Section 12(b)
of the Act:

  

 Title of each class
 Trading

 Symbol (s)
 Name of each exchange

 on which registered

 Common
 Stock, par value $0.0001 per share
 PARK
 The
 Nasdaq Stock
 Market LLC

  

 Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

  

 Emerging growth
company x

  

 If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

  

 * * *

  

  

  

  

  

  

 Item 5.07 Submission of Matters to a Vote of Security Holders.

  

 On May 29, 2026, Park Dental Partners, Inc. (the “Company”)
held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”) for the purposes of (i) electing the Class II
director named in the definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 10,
2026 (the “Proxy Statement”); and (ii) ratifying the appointment of Deloitte & Touche LLP as the Company’s
independent registered public accounting firm for the fiscal year ending December 31, 2026.

  

 As of the record date of March 30, 2026, there were 6,608,919
shares of the Company’s common stock, par value $0.0001 per share, entitled to vote at the Annual Meeting, including restricted
shares entitled to vote prior to vesting. A total of 5,279,595 shares were represented in person or by proxy at the Annual Meeting, constituting
a quorum. The final results of the shareholder vote are set forth below.

  

 Proposal 1: Election of Director

  

 The Company’s shareholders elected Christopher C. Smith as a
Class II director to serve until the Company’s 2029 annual meeting of shareholders and until his successor is duly elected
and qualified. The director was elected by the votes indicated.

  

 Nominee  
 For    
 Withheld    
 Broker Non-Votes  

 Christopher C. Smith  
   4,214,835    
   586,587    
   478,173  

  

 Proposal 2: Ratification of Appointment of Independent Registered
Public Accounting Firm

  

 The Company’s shareholders ratified the appointment of Deloitte &
Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The
appointment was ratified by the votes indicated.

  

 For  
 Against    
 Abstain    
 Broker Non-Votes  

 5,145,444  
   1,047    
   133,104    
        0  

  

 Item 9.01 Financial Statements and Exhibits.

  

 (d) Exhibits.

  

 Exhibit No.
 Description

  
  

 104
 Cover Page Interactive Data File (formatted as Inline XBRL).

  

 * * *

  

  

  

  

 SIGNATURES

  

 Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

  
 PARK DENTAL PARTNERS, INC.

  
  

 Date: June 2, 2026
 By:
 /s/ Peter G. Swenson

  
 Name: Peter G. Swenson

  
 Title: Chief Executive Officer and Chair